GEA GROUP
5-year stock timeline
As of 2026-05-20 the latest GEA Group (G1A.XETRA) price is 55.7; below is a concise, factual 2020–2026 timeline of material company and stock-specific events, how investor narrative evolved, and the key chart phases that mattered.
Major company events
GEA weathered the COVID-19 shock in 2020 with only modest revenue decline and improved profitability thanks to efficiency programs and selective demand resilience in pharma, chemical and dairy segments. In 2021 management extended CEO Stefan Klebert's contract and authorized a large treasury-share program that signaled tangible capital-return intent. From late 2023 through 2025 GEA ran and then completed a large share buyback—a EUR 400m program with purchases and planned cancellations of prior treasury shares—while delivering rising margins and raising dividends as it announced mid-term targets were met ahead of schedule and launched a new long-term plan.
Investor perception and narrative
Early 2020 coverage shifted to a "resilient industrial engineering" story as GEA demonstrated operational stability during the pandemic. During 2022 the narrative turned cautious as macro shocks—notably the war in Ukraine, inflation and supply-chain stress—pressured order visibility even as underlying execution remained credible. From 2023–2025 the stock narrative pivoted toward capital-efficiency and quality: investors emphasized margin expansion, strong ROCE, recurring service revenue growth, and active buybacks and dividend increases that supported a re-rating.
Key technical phases
Crash and rebound (Q1 2020 → 2021): the pandemic-driven drawdown was followed by recovery as operational resilience became clear and order intake normalized. Volatile and sideways (2022): macro uncertainty produced a consolidation range with periodic selloffs tied to broader industrial cyclicality and inflation worries. Uptrend and re-rating (2023 → 2025+): improved margins, Mission-26 target achievement, a large buyback and rising dividends coincided with a multi-quarter uptrend and multiple compression reversal that reduced free float and supported higher valuation levels into 2025–2026.
If a short annotated price-timeline or chart-level list of specific support and resistance levels is wanted, provide the preferred price points or timeframes and the timeline can be tightened to those.
Key risks and downside factors
GEA Group competes in a fragmented global market for food, beverage, and pharma-processing equipment, where large engineering firms and specialized manufacturers overlap considerably in what they offer. This creates relentless pressure on both products and service pricing [1]. The company faces real headwinds: project execution risk, margin compression from cheaper competitors, cyclical demand from customers, and the unpredictable capital spending shifts driven by regulatory and sustainability requirements. When those shifts happen, revenues can tighten and working capital demands spike [7].
- Execution and delivery risk on large turnkey plants—the kind that tends to produce cost overruns and margin compression when things slip.
- Pricing pressure from low-cost global suppliers—particularly Chinese component makers—in key markets, with margin compression as the result.
- End market cyclicality in food & beverage capex and industrial processing is driving order intake volatility.
- Regulatory, sanitary, and sustainability requirements are lifting compliance costs and capital intensity across the board.
Competitive landscape
GEA Group operates in a competitive landscape anchored by established global players—Alfa Laval, Krones, Andritz—and specialized competitors like SPX Flow and Marel. Private operators including Tetra Laval and Bühler also compete for share, while PE-backed consolidators and lower-cost Chinese manufacturers create persistent pricing pressure, particularly across Asia-Pacific. The business carries inherent cyclicality tied to capital-equipment spending, faces margin risk from cost competitors and industry consolidation, and contends with exposure to supply-chain disruption and commodity volatility. Food and pharma operations carry additional regulatory and product-safety considerations.
| Company | Ticker |
|---|---|
| Alfa Laval AB | ALFA.ST |
| Andritz AG | ANDR.VI |
Private competitors
- Tetra Laval Group
- Bühler Group
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialPerformance Figures of GEA GROUP
Relative Performance vs Benchmarks
| Period | GEA GROUP | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | -8.73% | -8.97% | -12.26% |
| 3M | -12.59% | -10.32% | -20.08% |
| 6M | -0.70% | -6.69% | -12.67% |
| 1Y | -5.00% | -6.83% | -30.18% |
| 3Y | +47.89% | -2.49% | -34.25% |
| 5Y | +77.31% | +18.76% | -12.02% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 21.7 | 1.7 | 3.5 | 14.6 |
| 1Y ago | 24.4 | 1.7 | 4.0 | 12.9 |
| 3Y ago | 16.9 | 1.3 | 3.0 | 16.1 |
| 5Y ago | 51.1 | 1.4 | 3.1 | 8.6 |
Frequently Asked Questions
Where is the GEA GROUP stock traded?
What does GEA GROUP do?
What are the key metrics for G1A.XETRA?
How has GEA GROUP's stock price performed?
How is G1A.XETRA valued?
Does G1A.XETRA pay dividends?
What are the key risks when investing in G1A.XETRA?
- Execution and delivery risk on large turnkey plants—the kind that tends to produce cost overruns and margin compression when things slip.
- Pricing pressure from low-cost global suppliers—particularly Chinese component makers—in key markets, with margin compression as the result.
- End market cyclicality in food & beverage capex and industrial processing is driving order intake volatility.
- Regulatory, sanitary, and sustainability requirements are lifting compliance costs and capital intensity across the board.
Who are the main competitors of GEA GROUP?
- Alfa Laval AB (ALFA.ST)
- Andritz AG (ANDR.VI)
When does GEA GROUP report earnings?
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 1.30 EUR | 2.20% | 2.17% |
| 2025 | 1.15 EUR | 2.01% | |
| 2024 | 1.00 EUR | 2.64% | |
| 2023 | 0.95 EUR | 2.20% | |
| 2022 | 0.90 EUR | 2.40% | |
| 2021 | 0.85 EUR | 2.33% | |
| 2020 | 0.43 EUR | 1.48% | |
| 2020 | 0.42 EUR | 2.00% | |
| 2019 | 0.85 EUR | 3.34% | |
| 2018 | 0.85 EUR | 2.46% | |
| 2017 | 0.80 EUR | 2.07% | |
| 2016 | 0.80 EUR | 1.90% | |
| 2015 | 0.70 EUR | 1.53% | |
| 2014 | 0.60 EUR | 1.86% | |
| 2013 | 0.55 EUR | 2.16% |
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 5.50B | 5.42B | 5.37B | 5.16B | 4.70B |
| Operating income (EBIT) | 639.78M | 593.03M | 504.90M | 466.88M | 380.90M |
| Net income | 414.01M | 385.04M | 392.76M | 401.43M | 305.17M |
| Free cash flow | 472.94M | 473.01M | 305.21M | 265.53M | 552.15M |
| Total assets | 6.09B | 6.03B | 5.95B | 5.92B | 5.87B |
| Equity | 2.45B | 2.42B | 2.40B | 2.28B | 2.08B |
| Net debt | -378.94M | -326.14M | -367.19M | -329.97M | -499.66M |
PWP Leeway UG (haftungsbeschränkt)
